Clinical Trials Browser

Phase 1 × Suspended × spartalizumab × Clear all

NCT05155332 2026-05-20

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Phase 1 Suspended

Other solid neoplasm

Solid Tumors